14
Participants
Start Date
February 28, 2011
Primary Completion Date
August 31, 2015
Study Completion Date
August 31, 2015
exenatide
exenatide 5mcg sq twice daily for one month and exenatide 10mcg twice daily for month 2. The 3rd month is a washout period. Month 4 and 5 saline placebo is given as 5mcg and 10mcg respectively.
Saline
Month 1 and 2 saline placebo is given as a low and high dose respectively. The 3rd month is a washout period. Month 4 exenatide 5mcg sq twice daily and for month 5 exenatide 10mcg twice daily is administered.
University of Alabama at Birmingham, Birmingham
Collaborators (1)
Amylin Pharmaceuticals, LLC.
INDUSTRY
University of Alabama at Birmingham
OTHER